Authors:
Bichel, T
Rouge, JC
Schlegel, S
Spahr-Schopfer, I
Kalangos, A
Citation: T. Bichel et al., Epidural sufentanil during paediatric cardiac surgery: effects on metabolic response and postoperative outcome, PAEDIATR AN, 10(6), 2000, pp. 609-617
Citation: S. Schlegel et B. Teichgraber, Operational results and experience with submerged fixed-film reactors in the pretreatment of industrial effluents, WATER SCI T, 41(4-5), 2000, pp. 453-459
Authors:
Grunder, G
Muller, MJ
Andreas, J
Heydari, N
Wetzel, H
Schlosser, R
Schlegel, S
Nickel, O
Eissner, D
Benkert, O
Citation: G. Grunder et al., Occupancy of striatal D-2-like dopamine receptors after treatment with thesigma ligand EMD 57445, a putative atypical antipsychotic, PSYCHOPHAR, 146(1), 1999, pp. 81-86
Authors:
Szegedi, A
Anghelescu, I
Wiesner, J
Schlegel, S
Weigmann, H
Hartter, S
Hiemke, C
Wetzel, H
Citation: A. Szegedi et al., Addition of low-dose fluvoxamine to low-dose clozapine monotherapy in schizophrenia: Drug monitoring and tolerability data from a prospective clinical trial, PHARMACOPS, 32(4), 1999, pp. 148-153
Authors:
Roschke, J
Kogel, P
Wagner, P
Grozinger, M
Hevers, W
Schlegel, S
Citation: J. Roschke et al., Electrophysiological evidence for an inverse benzodiazepine receptor agonist in panic disorder, J PSYCH RES, 33(1), 1999, pp. 1-5
Authors:
Loerch, B
Graf-Morgenstern, M
Hautzinger, M
Schlegel, S
Hain, C
Sandmann, J
Benkert, O
Citation: B. Loerch et al., Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia, BR J PSYCHI, 174, 1999, pp. 205-212
Authors:
Anghelescu, I
Szegedi, A
Schlegel, S
Weigmann, H
Hiemke, C
Wetzel, H
Citation: I. Anghelescu et al., Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial, EUR NEUROPS, 8(4), 1998, pp. 315-320